Lisinopril, an angiotensin-converting enzyme inhibitor (ACEI) for the treatment of hypertension [25,26], was chosen due to its hydrophilicity, and spironolactone, a potassium-sparing diuretic for the treatment of hypertension and congestive heart failure [27], was selected because of its hydrophobicity. Here, ACE is linked to hypertensive disorder.